Nicholas C Nicolaides

3PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 20, 2025
ICAM-1 Is Overexpressed by Cancers and Negatively Impacts Antibody-Based Therapies Including Antibody-Drug Conjugates.

J Bradford Kline, Luigi Grasso, Nicholas C Nicolaides

|May 17, 2023
NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects.

Nicholas C Nicolaides, J Bradford Kline, Luigi Grasso

|Aug 26, 2018
Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding.

J Bradford Kline, Shawn Fernando, Erin N Ross

Pageof 1

Frequent Collaborators

1 joint publications

J Bradford Kline